As at July 31, 2015 the Company had 75,202,620 royalty preferred shares outstanding, all of which were held by Zenith Epigenetics Corp. (“Zenith”). On July 2, 2015, the Company’s articles were amended to make certain changes to the dividend entitlement of holders of royalty preferred shares. Please feel free to pokes holes in anything I've said so far. PVLee